Plans for the acquisition were announced in December. The move pushes Henry Schein, a dental medtech company, into the orthopedic space.
TriMed had 2023 net sales of about $52 million, and the company develops products for the lower and upper extremities. David Medoff, TriMed’s chief commercial officer, and Robert Medoff, MD, medical advisor, will remain part of the company’s management team.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
